We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$475B
AUM Growth
+$26B
Cap. Flow
-$6.36B
Cap. Flow %
-1.34%
Top 10 Hldgs %
16.2%
Holding
2,616
New
108
Increased
1,286
Reduced
995
Closed
102

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.54B
2
VIPS icon
Vipshop
VIPS
+$825M
3
HON icon
Honeywell
HON
+$813M
4
EL icon
Estee Lauder
EL
+$804M
5
GE icon
GE Aerospace
GE
+$787M

Sector Composition

Rank Sector Weight
1 Healthcare 22.49%
2 Consumer Discretionary 15.06%
3 Financials 13.94%
4 Technology 11.82%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
51
DELISTED
Hanesbrands
HBI
$1.96B 0.41%
66,721,223
+5,013,151
+8% +$150M
BABA icon
52
Alibaba
BABA
$306B
$1.96B 0.41%
24,109,003
+3,166,659
+15% +$248M
BIIB icon
53
Biogen
BIIB
$30.1B
$1.95B 0.41%
6,360,432
+333,346
+6% +$95.8M
STT icon
54
State Street
STT
$51.4B
$1.92B 0.4%
28,983,317
-1,672,964
-5% -$116M
MET icon
55
MetLife
MET
$61.5B
$1.89B 0.4%
43,983,827
+3,861,629
+10% +$170M
TSLA icon
56
Tesla
TSLA
$1.31T
$1.89B 0.4%
118,062,240
-2,109,345
-2% -$31.6M
CI icon
57
Cigna
CI
$72.4B
$1.87B 0.39%
12,783,413
-2,471,781
-16% -$340M
BAC icon
58
Bank of America
BAC
$448B
$1.85B 0.39%
110,067,893
+582,911
+0.5% +$9.86M
ORLY icon
59
O'Reilly Automotive
ORLY
$74.9B
$1.83B 0.38%
108,065,025
-3,103,200
-3% -$53.8M
FE icon
60
FirstEnergy
FE
$27.1B
$1.82B 0.38%
57,336,722
-13,250,782
-19% -$416M
CVS icon
61
CVS Health
CVS
$120B
$1.82B 0.38%
18,604,406
-3,375,033
-15% -$331M
WBA
62
DELISTED
Walgreens Boots Alliance
WBA
$1.82B 0.38%
21,356,676
+2,225,304
+12% +$189M
MGM icon
63
MGM Resorts International
MGM
$11.1B
$1.79B 0.38%
78,779,146
+3,316,510
+4% +$73.2M
CP icon
64
Canadian Pacific Kansas City
CP
$80.8B
$1.76B 0.37%
68,816,410
+22,564,435
+49% +$634M
MDT icon
65
Medtronic
MDT
$116B
$1.73B 0.36%
22,489,045
-151,716
-0.7% -$11.4M
HUM icon
66
Humana
HUM
$44.8B
$1.72B 0.36%
9,613,295
+152,330
+2% +$26.7M
CMCSA icon
67
Comcast
CMCSA
$91B
$1.69B 0.36%
60,020,038
+18,396,770
+44% +$554M
AMTD
68
DELISTED
TD Ameritrade Holding Corp
AMTD
$1.68B 0.35%
48,478,274
-318,262
-0.7% -$11.1M
TMUS icon
69
T-Mobile US
TMUS
$192B
$1.66B 0.35%
42,353,940
+4,019,000
+10% +$155M
HD icon
70
Home Depot
HD
$353B
$1.65B 0.35%
12,475,510
+124,147
+1% +$15.8M
TXT icon
71
Textron
TXT
$15.2B
$1.64B 0.34%
39,027,144
+1,304,298
+3% +$53.9M
LLY icon
72
Eli Lilly
LLY
$1.08T
$1.59B 0.33%
18,885,220
+106,659
+0.6% +$8.85M
JCI icon
73
Johnson Controls International
JCI
$93.7B
$1.59B 0.33%
38,425,812
+1,152,761
+3% +$52.1M
VRSN icon
74
VeriSign
VRSN
$26B
$1.57B 0.33%
17,996,062
+1,919,134
+12% +$160M
PEP icon
75
PepsiCo
PEP
$189B
$1.56B 0.33%
15,632,064
-1,316,942
-8% -$131M

Similar funds

T. Rowe Price Associates's Q4 2015 Portfolio in Review

As of Q4 2015, T. Rowe Price Associates held 2,616 positions worth $475B, up 5.8% from $449B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q4 2015 filing shows 108 new, 1,286 increased, 995 reduced and 102 closed positions. Its largest new stake was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B. The largest sale was Alphabet (Google) Class C, an estimated $5.54B.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B.
  • T. Rowe Price Associates added most to PayPal in Q4 2015, an estimated $722M increase.
  • T. Rowe Price Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $5.54B.
  • T. Rowe Price Associates fully exited CYTEC INDS INC in Q4 2015, selling an estimated $610M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $475B portfolio in Q4 2015.
  • T. Rowe Price Associates opened 108 new positions and closed 102 in Q4 2015.
  • T. Rowe Price Associates's portfolio value rose 5.8% quarter-over-quarter to $475B.

Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.